Information Journal Paper
APA:
CopyITO, A., ISHIDA, T., & YANO, H.. (2009). DEFUCOSYLATED ANTI-CCR4 MONOCLONAL ANTIBODY EXERCISES POTENT ADCC-MEDIATED ANTITUMOR EFFECT IN THE NOVEL TUMOR-BEARING HUMANIZED NOD/SHI-SCID, IL-2 RGAMMA(NULL) MOUSE MODEL. CANCER IMMUNOLOGY, IMMUNOTHERAPY, 58(8), 1195-1206. SID. https://sid.ir/paper/652743/en
Vancouver:
CopyITO A., ISHIDA T., YANO H.. DEFUCOSYLATED ANTI-CCR4 MONOCLONAL ANTIBODY EXERCISES POTENT ADCC-MEDIATED ANTITUMOR EFFECT IN THE NOVEL TUMOR-BEARING HUMANIZED NOD/SHI-SCID, IL-2 RGAMMA(NULL) MOUSE MODEL. CANCER IMMUNOLOGY, IMMUNOTHERAPY[Internet]. 2009;58(8):1195-1206. Available from: https://sid.ir/paper/652743/en
IEEE:
CopyA. ITO, T. ISHIDA, and H. YANO, “DEFUCOSYLATED ANTI-CCR4 MONOCLONAL ANTIBODY EXERCISES POTENT ADCC-MEDIATED ANTITUMOR EFFECT IN THE NOVEL TUMOR-BEARING HUMANIZED NOD/SHI-SCID, IL-2 RGAMMA(NULL) MOUSE MODEL,” CANCER IMMUNOLOGY, IMMUNOTHERAPY, vol. 58, no. 8, pp. 1195–1206, 2009, [Online]. Available: https://sid.ir/paper/652743/en